A pediatric PAH patient harboring a homozygous nonsense p.[Gln26Ter] BMP9 mutation, predicted to lead to an absence of BMP9 protein, has been reported but BMP9 levels were not assessed in this patient (Wang et al., 2016). This evidence concerns the gene GDF2 and pulmonary arterial hypertension.